Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S351000, C514S343000, C514S342000, C514S334000, C514S318000, C514S253120, C514S237200, C514S235500, C544S131000, C546S299000, C546S298000, C546S257000, C546S279100, C546S269700, C546S194000
Reexamination Certificate
active
10525608
ABSTRACT:
The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
REFERENCES:
patent: 3925395 (1975-12-01), Bayer
patent: 02 053541 (2002-11-01), None
Palomo et al. (J. Org. Chem. 1991, 56, 4418-4428).
Walker et al. (CMLS, Cell. Mol. Life Sci. 58 (2001) 596-624.
Abbenante et al (Medicinal Chemistry, 2005, 1, 71-104.
Abstract of Chughtai et al. (Journal of Aerosol Medicine, 2004, 17(4), 289-298).
Albrecht Barbara
Allerheiligen Swen
Bärfacker Lars
Fitzgerald Mary F.
Gielen-Haertwig Heike
Bayer Healthcare AG
McKane Joseph K.
Nolan Jason M.
LandOfFree
Dihydropyridinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydropyridinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropyridinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3819174